Managed Healthcare Executive September 4, 2024
The growth of out-of-pocket and insurer/negotiated prices paralleled one another until 2016 when negotiated and insurer prices began declining
This story first appeared on American Journal of Managed Care Pharmacy.
Today, an analysis published in Health Affairs took a deeper look into how out-of-pocket prices and manufacturer rebates factor into the complexities behind pharmaceutical costs. This investigation revealed that the out-of-pocket drug prices faced by consumers have grown quicker over time than those encountered by insurers.1
“The complexity and lack of transparency in pharmaceutical pricing make it difficult to discern the true costs of drugs,” the authors state. The topic of drug costs has been an important ongoing issue in the United States, especially considering the results of a 2023...
Today's Sponsors
Today's Sponsor